GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » Total Long-Term Assets

Nextbiomedical Co (XKRX:389650) Total Long-Term Assets : ₩12,335 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Nextbiomedical Co Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Nextbiomedical Co's Total Long-Term Assets for the quarter that ended in Mar. 2025 was ₩12,335 Mil.


Nextbiomedical Co Total Long-Term Assets Historical Data

The historical data trend for Nextbiomedical Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextbiomedical Co Total Long-Term Assets Chart

Nextbiomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
15,276.31 15,981.34 14,615.19 11,675.00 11,956.64

Nextbiomedical Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,675.00 11,631.73 27,440.57 11,956.64 12,335.00

Nextbiomedical Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


Nextbiomedical Co Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Nextbiomedical Co's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Nextbiomedical Co Business Description

Traded in Other Exchanges
N/A
Address
Venture-ro, No. 6, 100 beongil, Yeonsu-gu, Incheon, KOR
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.

Nextbiomedical Co Headlines

No Headlines